← Eichor
Condition: Migraine In Adolescence Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Migraine In Adolescence

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Puberty, Testosterone, and Brain Development
Phase N/A · 1 location(s) · University of Colorado, Denver · NCT06670053Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
Phase 3 · 90 location(s) · Pfizer · NCT05156398A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine
Phase 3 · 102 location(s) · Pfizer · NCT06616194A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine
Phase 3 · 84 location(s) · H. Lundbeck A/S · NCT04965675nVNS for the Prevention and Treatment of Primary Headache
NA · 1 location(s) · Nanfang Hospital, Southern Medical University · NCT06277063Migraine in Adolescents
NA · 1 location(s) · Washington University School of Medicine · NCT05654012Cannabis for Chronic Headaches in Adolescents: the CAN-CHA Trial
Phase 2 · 3 location(s) · University of Manitoba · NCT05337033Overlapping Pain Trajectory Study
Phase N/A · 1 location(s) · Children's Hospital Medical Center, Cincinnati · NCT05752396Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
Phase 3 · 125 location(s) · Pfizer · NCT04743141Association of Helicobacter Pylori Infection and Migraine
NA · 1 location(s) · Sohag University · NCT06558578A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
Phase 3 · 70 location(s) · H. Lundbeck A/S · NCT05164172Randomized Study in Children and Adolescents With Migraine: Acute Treatment
Phase 3 · 246 location(s) · Pfizer · NCT04649242Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Ch
Phase 3 · 129 location(s) · AbbVie · NCT05125302
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.